Saturday , 17 August 2019
Breaking News

Tag Archives: aurobindo

Aurobindo Pharma launches Cinacalcet Hydrochloride Tablets

Aurobindo Pharma has launched Cinacalcet Hydrochloride Tablets (30mg, 60mg and 90mg) at risk in the US market in accordance with the terms of settlement agreement with Amgen Inc. Aurobindo’s Cinacalcet Hydrochloride tablets 30mg, 60mg and 90mg is a generic version of Amgen Inc’s Sensipar tablets, Cinacalcet Hydrochloride tablets had an annual sale of approximately $1,449 million for the twelve months ... Read More »

USFDA classifies inspection concluded at Aurobindo Pharma’s API facilities

Aurobindo Pharma has received letters from the US Food and Drug Administration (USFDA) classifying the inspections concluded at its API facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated (OAI). The company has already submitted its initial response to USFDA. The company is sending further updates on the committed corrective ... Read More »